journal article·2009-04

Effect of organic and inorganic acids on chitosan/glycerophosphate thermosensitive hydrogel

Qing Sheng Zhao, Xiao Jie Cheng, Qiu Xia Ji, Chuan Zhen Kang, Xi Guang Chen

Publisher page

Abstract

The influence of organic and inorganic acids on chitosan/glycerophosphate (CS/GP) hydrogel has been investigated by dissolving chitosan in different acids. The results of gelation showed that all of the chitosan dissolved in monovalent acid solutions (i.e., formic, acetic, propionic, butyric, isobutyric, lactic, nitric, hydrochloric, and chloroacetic acid), when neutralized by GP solution, could transform into hydrogel after 2–5 min at 37 °C, while those dissolved in multivalent acids failed in gel formation. The inner structures of CS/GP hydrogels prepared with monovalent acids depended on the ionic strength and chain length of acids. Morphological examination by scanning electron microphotography demonstrated that large pores occurred during the gel-forming process, and the aperture size was also related to different acids. The cytotoxicity studies indicated that CS/GP systems prepared by dissolving chitosan in tested acids except chloroacetic acid were nontoxic to mouse embryonic fibroblasts and Hela cells.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Ueno H, Mori T, Fujinag T (2001) Adv Drug Deliv Rev 52:105. doi: 10.1016/S0169-409X(01)00189-210.1016/S0169-409X(01)00189-2 ↗
2. George M, Abraham TE (2006) J Control Release 114:1. doi: 10.1016/j.jconrel.2006.04.01710.1016/j.jconrel.2006.04.017 ↗
3. Sato T, Ishii T, Okahata Y (2001) Biomaterials 22:2075. doi: 10.1016/S0142-9612(00)00385-910.1016/S0142-9612(00)00385-9 ↗
4. Romøren K, Thu BJ, Evensen Ø (2002) J Control Release 85:215. doi: 10.1016/S0168-3659(02)00278-X10.1016/S0168-3659(02)00278-X ↗
5. Germershaus O, Mao S, Sitterberg J, Bakowsky U, Kissel T (2008) J Control Release 125:145. doi: 10.1016/j.jconrel.2007.10.01310.1016/j.jconrel.2007.10.013 ↗
6. Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, Yura H, Matsui T, Hattori H, Uenoyamaa M, Kurita A (2002) Biomaterials 23:833. doi: 10.1016/S0142-9612(01)00189-210.1016/S0142-9612(01)00189-2 ↗
7. Peppas NA, Bures P, Leobandung W, Ichikawa H (2000) Eur J Pharm Biopharm 50:27. doi: 10.1016/S0939-6411(00)00090-410.1016/S0939-6411(00)00090-4 ↗
8. Wu J, Wei W, Wang LY, Su ZG, Ma GH (2007) Biomaterials 28:2220. doi: 10.1016/j.biomaterials.2006.12.02410.1016/j.biomaterials.2006.12.024 ↗
9. Richardson SM, Hughes N, Hunt JA, Freemont AJ, Hoyland JA (2008) Biomaterials 29:85. doi: 10.1016/j.biomaterials.2007.09.01810.1016/j.biomaterials.2007.09.018 ↗
10. Crompton KE, Goud JD, Bellamkonda RV, Gengenbach TR, Finkelstein DI, Horne MK, Forsythe JS (2007) Biomaterials 28:441. doi: 10.1016/j.biomaterials.2006.08.04410.1016/j.biomaterials.2006.08.044 ↗
11. Wu J, Su ZG, Ma GH (2006) Int J Pharm 315:1. doi: 10.1016/j.ijpharm.2006.01.04510.1016/j.ijpharm.2006.01.045 ↗
12. Shim WS, Kim JH, Park H, Kim K, Kwon IC, Lee DS (2006) Biomaterials 27:5178. doi: 10.1016/j.biomaterials.2006.05.03810.1016/j.biomaterials.2006.05.038 ↗
13. George M, Abraham TE (2007) Int J Pharm 335:123. doi: 10.1016/j.ijpharm.2006.11.00910.1016/j.ijpharm.2006.11.009 ↗
14. Uraki Y, Imura T, Kishimoto T, Ubukata M (2004) Carbohydr Polym 58:123. doi: 10.1016/j.carbpol.2004.05.01910.1016/j.carbpol.2004.05.019 ↗
15. Ninomiya A, Kawaguchi H (2006) Sci Technol Adv Mater 7:162. doi: 10.1016/j.stam.2005.12.00510.1016/j.stam.2005.12.005 ↗
16. Matzelle MM, Babensee JE (2004) Biomaterials 25:295. doi: 10.1016/S0142-9612(03)00531-310.1016/S0142-9612(03)00531-3 ↗
17. Chenite A, Buschmann M, Wang D, Chaput C, Kanadani N (2001) Carbohydr Polym 46:39. doi: 10.1016/S0144-8617(00)00281-210.1016/S0144-8617(00)00281-2 ↗
18. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A (2000) Biomaterials 21:2155. doi: 10.1016/S0142-9612(00)00116-210.1016/S0142-9612(00)00116-2 ↗
19. Sharma G, Italia JL, Sonaje K, Tikoo K, Kumar MNVR (2007) J Control Release 118:27. doi: 10.1016/j.jconrel.2006.11.02610.1016/j.jconrel.2006.11.026 ↗
20. Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Garrec DL, Chenite A, Leroux JC (2004) Eur J Pharm Biopharm 57:53. doi: 10.1016/S0939-6411(03)00095-X10.1016/S0939-6411(03)00095-X ↗
21. Berrada M, Serreqi A, Dabbarh F, Owusu A, Gupta A, Lehnert S (2005) Biomaterials 26:2115. doi: 10.1016/j.biomaterials.2004.06.01310.1016/j.biomaterials.2004.06.013 ↗
22. Han HD, Song CK, Park YS, Noh KH, Kim JH, Hwang T, Kim TW, Shin BC (2008) Int J Pharm 350:27. doi: 10.1016/j.ijpharm.2007.08.01410.1016/j.ijpharm.2007.08.014 ↗
23. Hoemann CD, Hurtig M, Rossomacha E, Sun J, Chevrier A, Shive MS, Buschmann MD (2005) J Bone Joint Surg Am 87:2671. doi: 10.2106/JBJS.D.0253610.2106/JBJS.D.02536 ↗
24. Hoemann CD, Sun J, Sc M, McKee MD, Chevrier A, Rossomacha E, Rivard GE, Hurtig M, Buschmann MD (2007) Osteoarthritis Cartilage 15:78. doi: 10.1016/j.joca.2006.06.01510.1016/j.joca.2006.06.015 ↗
25. Roughley P, Hoemann C, DesRosiers E, Mwale F, Antoniou J, Alini M (2006) Biomaterials 27:388. doi: 10.1016/j.biomaterials.2005.06.03710.1016/j.biomaterials.2005.06.037 ↗
26. Kempe S, Metz H, Bastrop M, Hvilsom A, Contri RV, Mäder K (2008) Eur J Pharm Biopharm 68:26. doi: 10.1016/j.ejpb.2007.05.02010.1016/j.ejpb.2007.05.020 ↗
27. Ganji F, Abdekhodaie MJ, Ramazani A (2007) J Sol-Gel Sci Technol 42:47. doi: 10.1007/s10971-006-9007-110.1007/s10971-006-9007-1 ↗
28. Sharma G, Italia JL, Sonaje K, Tikoo K, Kumar MNVR (2007) J Control Release 118:27. doi: 10.1016/j.jconrel.2006.11.02610.1016/j.jconrel.2006.11.026 ↗
29. Zhou HY, Chen XG, Kong M, Liu CS, Cha DS, Kennedy JF (2008) Carbohydr Polym 73:265. doi: 10.1016/j.carbpol.2007.11.02610.1016/j.carbpol.2007.11.026 ↗
30. Orienti I, Cerchiara T, Luppi B, Bigucci F, Zuccari G, Zecchi V (2002) Int J Pharm 238:51. doi: 10.1016/S0378-5173(02)00060-110.1016/S0378-5173(02)00060-1 ↗
31. Ritthidej GC, Phaechamud T, Koizumi T (2002) Int J Pharm 232:11. doi: 10.1016/S0378-5173(01)00894-810.1016/S0378-5173(01)00894-8 ↗
32. Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK (2000) Int J Pharm 197:53. doi: 10.1016/S0378-5173(99)00451-210.1016/S0378-5173(99)00451-2 ↗
33. Yang ZQ, Song BZ, Li QX, Fan HL, Ouyang F (2004) China Particuol 2(2):70. doi: 10.1016/S1672-2515(07)60026-810.1016/S1672-2515(07)60026-8 ↗
34. Shamov MV, Bratskaya SY, Avramenko VA (2002) J Colloid Interface Sci 249:316. doi: 10.1006/jcis.2002.824810.1006/jcis.2002.8248 ↗
35. Chen XG, Liu CS, Liu CG, Meng XH, Lee CM, Park HJ (2006) Biochem Eng J 27:269. doi: 10.1016/j.bej.2005.08.02110.1016/j.bej.2005.08.021 ↗
36. Chung YM, Simmons KL, Gutowska A, Jeong B (2002) Biomacromolecules 3:511. doi: 10.1021/bm015643110.1021/bm0156431 ↗
37. Schuetz YB, Gurny R, Jordan O (2008) Eur J Pharm Biopharm 68:19. doi: 10.1016/j.ejpb.2007.06.02010.1016/j.ejpb.2007.06.020 ↗
38. Hamdine M, Heuzey MC, B’egin A (2005) Int J Biol Macromol 37:13410.1016/j.ijbiomac.2005.09.009 ↗
39. Ruel-Garie’py E, Leroux JC (2004) Eur J Pharm Biopharm 58:409. doi: 10.1016/j.ejpb.2004.03.01910.1016/j.ejpb.2004.03.019 ↗
40. Crompton KE, Prankerd RJ, Paganin DM, Scott TF, Horne MK, Finkelstein DI, Gross KA, Forsythe JS (2005) Biophys Chem 117:47. doi: 10.1016/j.bpc.2005.03.00910.1016/j.bpc.2005.03.009 ↗